Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.700
0.00 (0.00%)
Sep 3, 2026, 4:00 PM EDT - Market closed
Alzamend Neuro Income Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Quarter | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jan '26 Jan 31, 2026 | Oct '25 Oct 31, 2025 | Jul '25 Jul 31, 2025 | Apr '25 Apr 30, 2025 | Jan '25 Jan 31, 2025 | Oct '24 Oct 31, 2024 | Jul '24 Jul 31, 2024 | Apr '24 Apr 30, 2024 | Jan '24 Jan 31, 2024 | Oct '23 Oct 31, 2023 | Jul '23 Jul 31, 2023 | Apr '23 Apr 30, 2023 | Jan '23 Jan 31, 2023 | Oct '22 Oct 31, 2022 | Jul '22 Jul 31, 2022 | Apr '22 Apr 30, 2022 | Jan '22 Jan 31, 2022 | Oct '21 Oct 31, 2021 | Jul '21 Jul 31, 2021 |
Selling, General & Admin | 2.44 | 0.92 | 0.82 | 0.96 | 0.69 | 0.59 | 1.05 | 0.76 | 0.67 | 0.75 | 0.9 | 1.16 | 1.66 | 2.53 | 1.57 | 1.66 | 2.21 | 1.68 | 1.83 | 1.39 |
Research & Development | 0.43 | 1.28 | 0.18 | 1.74 | 0.45 | 0.45 | 0.31 | 0.21 | 0.18 | 1.91 | 2 | 2.37 | 1.65 | 2.89 | 1.53 | 1.38 | 1.66 | 0.87 | 1.75 | 0.92 |
Operating Expenses | 2.87 | 2.2 | 1 | 2.7 | 1.14 | 1.04 | 1.36 | 0.96 | 0.85 | 2.66 | 2.9 | 3.53 | 3.31 | 5.42 | 3.11 | 3.04 | 3.87 | 2.56 | 3.58 | 2.31 |
Operating Income | -2.87 | -2.2 | -1 | -2.7 | -1.14 | -1.04 | -1.36 | -0.96 | -0.85 | -2.66 | -2.9 | -3.53 | -3.31 | -5.42 | -3.11 | -3.04 | -3.87 | -2.56 | -3.58 | -2.31 |
Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0.01 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0.02 | -0.02 | -0.01 |
Interest & Investment Income | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBT Excluding Unusual Items | -2.87 | -2.2 | -1 | -2.7 | -1.14 | -1.04 | -1.36 | -0.97 | -0.85 | -2.66 | -2.91 | -3.53 | -3.31 | -5.43 | -3.11 | -3.04 | -3.87 | -2.57 | -3.6 | -2.32 |
Other Unusual Items | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | - | - | - |
Pretax Income | -2.87 | -2.2 | -1 | -2.7 | -1.14 | -1.04 | -1.36 | -0.97 | -0.85 | -2.66 | -2.91 | -3.53 | -3.31 | -5.43 | -3.11 | -3.04 | -3.87 | -2.57 | -3.6 | -2.32 |
Net Income | -2.87 | -2.2 | -1 | -2.7 | -1.14 | -1.04 | -1.36 | -0.97 | -0.85 | -2.66 | -2.91 | -3.53 | -3.31 | -5.43 | -3.11 | -3.04 | -3.87 | -2.57 | -3.6 | -2.32 |
Preferred Dividends & Other Adjustments | - | - | - | - | 0.5 | 0.03 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -2.87 | -2.2 | -1 | -2.7 | -1.64 | -1.07 | -1.36 | -0.97 | -0.85 | -2.66 | -2.91 | -3.53 | -3.31 | -5.43 | -3.11 | -3.04 | -3.87 | -2.57 | -3.6 | -2.32 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 4 | 4 | 3 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 4 | 4 | 3 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Change (YoY) | 457.27% | 521.71% | 761.59% | 2368.57% | 834.57% | 680.77% | 438.06% | 17.00% | 6.66% | 7.62% | 0.99% | 0.98% | 10.06% | 4.42% | 4.31% | 15.24% | 19.13% | 30.31% | 29.33% | 17.06% |
EPS (Basic) | -0.72 | -0.58 | -0.30 | -1.28 | -2.30 | -1.75 | -3.47 | -11.42 | -11.14 | -33.97 | -39.85 | -48.38 | -46.11 | -74.49 | -43.07 | -42.06 | -59.41 | -36.89 | -52.00 | -37.02 |
EPS (Diluted) | -0.72 | -0.58 | -0.30 | -1.28 | -2.30 | -1.75 | -3.47 | -11.42 | -11.14 | -33.97 | -39.85 | -48.38 | -46.11 | -74.49 | -43.07 | -42.06 | -59.41 | -36.89 | -52.00 | -37.02 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jan '26 Jan 31, 2026 | Oct '25 Oct 31, 2025 | Jul '25 Jul 31, 2025 | Apr '25 Apr 30, 2025 | Jan '25 Jan 31, 2025 | Oct '24 Oct 31, 2024 | Jul '24 Jul 31, 2024 | Apr '24 Apr 30, 2024 | Jan '24 Jan 31, 2024 | Oct '23 Oct 31, 2023 | Jul '23 Jul 31, 2023 | Apr '23 Apr 30, 2023 | Jan '23 Jan 31, 2023 | Oct '22 Oct 31, 2022 | Jul '22 Jul 31, 2022 | Apr '22 Apr 30, 2022 | Jan '22 Jan 31, 2022 | Oct '21 Oct 31, 2021 | Jul '21 Jul 31, 2021 |
Free Cash Flow | -2.8 | -1.74 | -1.17 | -2.36 | -0.9 | -1.42 | -3.4 | -1.15 | -1.43 | -2.03 | -1.51 | -3.45 | -2.24 | -1.81 | -2.34 | -2.54 | -1.67 | -1.78 | -2.05 | -1.22 |
Free Cash Flow Per Share | -0.70 | -0.46 | -0.35 | -1.12 | -1.26 | -2.33 | -8.66 | -13.43 | -18.66 | -25.92 | -20.75 | -47.25 | -31.18 | -24.81 | -32.46 | -35.13 | -25.62 | -25.56 | -29.56 | -19.51 |
EBITDA | -2.84 | -2.17 | -0.97 | -2.67 | -1.13 | -1.02 | -1.35 | -0.95 | -0.84 | -2.65 | -2.89 | -3.51 | -3.3 | -5.42 | -3.1 | -3.03 | -3.87 | - | - | - |
D&A For EBITDA | 0.03 | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | - | - | - |
EBIT | -2.87 | -2.2 | -1 | -2.7 | -1.14 | -1.04 | -1.36 | -0.96 | -0.85 | -2.66 | -2.9 | -3.53 | -3.31 | -5.42 | -3.11 | -3.04 | -3.87 | -2.56 | -3.58 | -2.31 |